A number of studies have found that upregulation of STEAP3 is strongly associated with poor prognosis in triple-negative breast cancer as well as gliomas, suggesting that STEAP3 may be used as a specific predictor [13, 14]. This evidence concerns the gene STEAP3 and central nervous system cancer.